New York Cardiovascular Symposium
December 8 − 10, 2017
New York Hilton Midtown
New York City

Course Director(s): Valentin Fuster, MD, PhD, MACC

Conflict of Interest (COI) Policy / Disclosures

ACCF committee members, faculty, staff and other individuals who are in a position to control the content of this activity are required to disclose all relevant financial relationships he/she and/or his/her spouse or domestic partner has, occurring within the past twelve months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, patient care and safety recommendations. Refer to the links below for committee member disclosures and course faculty disclosures. Please note ACCF staff involved with this course have nothing to disclose.

Friday, December 8

Coronary Artery Disease -- Challenges in 2017
Session I: New Frontiers
Dr. Bhatt, Presiding

7:30 a.m. Vascular 3D-Ultrasound in Subclinical Systemic Disease: 12,000 Subjects
Feasible, Predictable, Preventable, Futurable
Dr. Fuster
Download PDF
8:00 a.m. Intravascular Optical Coherence Tomography in Clinical CAD: 1,400 Patients
Feasibility, Predictability, Preventability, Futurability  

Dr. Jang
Download PDF
8:25 a.m. Genomics in Myocardial and Structural Heart Disease
From Generic to a Personalized Cardiovascular Approach

Dr. Seidman
Download PDF
8:50 a.m. Panel Discussion
Drs. Fuster, Jang, and Seidman

Session II: Acute Coronary Syndromes (ACS)
Dr. Levine, Presiding

9:40 a.m. STEMI 1: Timing, Mechanical Type and Pharmacology of Reperfusion
The Three Main Challenges to Decrease Infarct Size and Increase Viability

Dr. Ibáñez
Download PDF
10:05 a.m. SSTEMI 2: PCI of Culprit Lesion Alone vs. FFR Guided Complete Revascularization
Effects on Hard End Points, MACE and Cost Effectiveness

Dr. Bhatt

Download PDF
10:30 a.m. STEMI vs. NSTEMI vs. STABLE CAD – Post PCI Optimal DAPT Duration    
Scoring the Complexity of Stenting and Disease

Dr. Yeh

Download PDF
10:55 a.m. STEMI vs. NSTEMI vs. STABLE CAD – Five Challenging Cases  
Five Challenging Antithrombotic Approaches

Dr. Levine

Download PDF
11:25 a.m. Panel Discussion
Drs. Bhatt, Ibáñez, Levine and Yeh

Session III: Systemic Arterial Disease -- Chronic Coronary Disease, Stroke and Pulmonary Embolism
Dr. Douglas, Presiding

1:00 p.m. Chest Pain Evaluation: Possible vs. Probable CAD
No Test, Stress Test or CT Angio?

Dr. Douglas
Download PDF
1:20 p.m. Complex Stable CAD: Evolving Evaluation and Management Strategies
Evaluate: Anatomy (SYNTAX), Ischemia (IFR), Microcirculation (CT, MRI)
Manage: Optimal Medical Therapy (OMT), PCI (Stents), CABG (IMA)

Dr. Fuster

Download PDF
1:45 p.m. Acute Ischemic Stroke and Chronic Carotid Artery Stenosis
Two Entities with Novel Approaches

Dr. Brott

Download PDF
2:05 p.m. Pulmonary Emboli: Diagnosis Based on Suspicion and Management in 2017
Based on the Acute Severity and Degree of Chronic PH

Dr. Piazza

Download PDF
2:25 p.m. Panel Discussion
Drs. Brott, Douglas, Fuster and Piazza

Session IV: Trends and Challenges of Approaching Prevention
Dr. Rader, Presiding

3:15 p.m. Aspirin in Primary and Secondary Cardiovascular Disease Prevention:
Still Four Questions About Enteric Coated, Indicated Doses, Use in Diabetes, Use in PVD

Dr. Patrono
Download PDF
3:35 p.m. Lipid Evaluation and Management: Four Evolving “Advances”
Familial LDL-C, ApoB, HDL Efflux Capacity and PCSK9 Inhibitors

Dr. Rader

Download PDF
4:00 p.m. Hypertension (HBP) Evaluation and Management: Three Challenges
Identify Those with HBP, Reduce Salt (Amount?) and Personalize BP Target  

Dr. Spatz

Download PDF
4:25 p.m. Diabetes and Obesity: The Four “Hot Spots”
Mechanisms of Diabetes, New Agents for Macrovascular Diabetes
Weight vs. Obesity in AF, Bariatric Surgery

Dr. Fuster

Download PDF
4:50 p.m. Panel Discussion
Drs. Fuster, Patrono, Rader and Spatz

5:30 p.m. Adjournment  

Saturday, December 9

Cardio-pulmonary and Electrical Failure 2017
Session V: Systolic Heart Failure and Basis for Management
Dr. Mann, Presiding

7:00 a.m. Imaging (Echo, MRI, PET) as Diagnostic and Prognostic Tools
For Seven Cardiomyopathies: Myocarditis, Dilated CM, Hypertrophic CM,
Noncompaction LV, Amyloid CM, Sarcoid and Takotsubo

Dr. Bonow
Download PDF
7:25 a.m. Therapeutic Approaches to Three Specific Cardiomyopathies
Acute/Subacute Myocarditis, AL/TTR Amyloid, Non-compaction LV  

Dr. Dec

Download PDF
7:50 a.m. Systolic and Diastolic Dysfunction:
Three Upcoming Challenges Promoting Early Detection
HFrEF: Beyond Neprilysin/Enalapril
HFmrEF: What Is It and How Does One Manage It?
HFpEF: Etiopathogenetic Role and Impact of Comorbidities  

Dr. Mann

Download PDF
8:20 a.m. Advanced Heart Failure ΜΆ The Three Upcoming Challenges
Acute Heart Failure: Is It a Disease that Can Be Treated?
Comorbidities in Heart Failure: Emerging Positive Signals
End Stage Heart Failure: Are We Doing Better?

Dr. O’Connor
Download PDF
8:45 a.m. State-of-the-Art Management of Pulmonary Hypertension
Monitoring and Approach of the Three Main Etiopathogenesis
L-Sided Failure, Pulmonary Arterial Hypertension, Thromboembolic

Dr. Gomberg-Maitland

Download PDF
9:10 a.m. Panel Discussion
Drs. Bonow, Dec, Gomberg-Maitland, Mann and O'Connor

Session VI: Rhythm Disorders, Contemporary and Future Topics of Focus
Dr. Reddy, Presiding

10:00 a.m. Innovations in Device Therapies: Three Approaches
CRTs, the Right Indications, Subcutaneous ICDs, Leadless Pacemakers 
Dr. Wilber
Download PDF
10:25 a.m. Ventricular Tachycardia: Catheter Ablation – Four Questions
Who? When? How? Results?

Dr. Reddy
Download PDF
10:50 a.m. Atrial Fibrillation: Catheter Ablation – Four Questions
Who? When? How? Results?

Dr. Marchlinski

Download PDF
11:15 a.m. Left Atrial Appendage Closure: Four Questions
Who? When? How? Results?

Dr. Holmes

Download PDF
11:40 a.m. Atrial Fibrillation 2017: The Fourteen Non-ablation Clinical Challenges
Quality of Life and Preventing Stroke

Dr. Fuster
Download PDF
12:00 p.m. Panel Discussion
Drs. Fuster, Holmes, Marchlinski, Reddy and Wilber

Valvular Heart Disease and Aorta – Challenges in 2017
Management of Aortic Valve Disease and Aorta
Dr. O'Gara, Presiding

1:30 p.m. Aortic Valvular Stenosis: How to Assess the Four Variables for Management
Low Flow / Low Gradient / Normal EF / Low EF

Dr. O'Gara
Download PDF
1:50 p.m. Severe Aortic Valvular Disease: TAVR in Four Ages and Four Etiologies
Age 25 y/o Congenital, 50 y/o Bicuspid, 75 y/o Rheumatic, 100 y/o Degenerative

Drs. Adams, Nishimura and Sharma

Download PDF (Panel)
Download PDF (Sharma)
2:20 p.m. The Dilated Thoracic and Abdominal Aorta and Complicating Dissection
Evolving Understanding of the Basic Biology and Management

Dr. Fuster
Download PDF
2:45 p.m. Panel Discussion
Drs. Adams, Fuster, O'Gara, Nishimura and Sharma

Session VIII: Management of Mitral Regurgitation and Hypertrophic Cardiomyopathy
Dr. Adams, Presiding

3:35 p.m. Significant Mitral Regurgitation (EF, LVEdD, PH or AF): Five Challenges
Two Etiologies (Primary, Secondary), Three Approaches (Medical, Clipping, Surgical)

Drs. Adams, Bonow and Sharma
Download PDF (Sharma)
Download PDF (Adams)
4:05 p.m. Transcatheter Replacement for Mitral and Tricuspid Regurgitation
Evolving Approaches Under Investigation

Dr. Rodés-Cabau
Download PDF
4:30 p.m. Hypertrophic Cardiomyopathy: Four Challenging Questions
Genetics/Acquired, Myectomy/Three Types, Natural Hx/ICD, Apical Aneurysm

Dr. Nishimura
Download PDF
4:55 p.m. Panel Discussion
Drs. Adams, Bonow, Nishimura, Rodés-Cabau and Sharma

5:30 p.m. Adjournment  

Sunday, December 10

Year in Review: The Nine Highlights of Progress in Dr. Fuster, Presiding
Session IX: Novelties on Genetics, Molecular Signaling and Cell Regeneration

Dr. Fuster, Presiding

7:30 a.m. Part 1: Progress in Genetic Medicine – Genome Editing
A New Understanding of Cardiovascular Physiology, Pathology and Future Therapies

Dr. Musumuru
Download PDF
7:55 a.m. Part 2: Progress in Molecular Cardiovascular Medicine – MicroRNAs,
Proteomics and Metabolomics
A New Understanding of Cardiovascular Physiology, Pathology and Future Therapies

Dr. Mayr
Download PDF
8:20 a.m. Part 3: Progress in Myocardial Regeneration – Exosomes and iPCs
A New Understanding of Cardiovascular Physiology, Pathology and Future Therapies 

Dr. Janssens
Download PDF

Session X: Novelties on Diagnostic and Therapeutic Strategies

8:45 a.m. Part 1: Evolving Progress of Cardiovascular Imaging
Redefining Its Role in Biomedical Research and Clinical Practice

Dr. Di Carli
Download PDF
9:10 a.m. Part 2: Evolving Progress of Coronary Interventional Stents
Bioresorbable Scaffolds – Moving Forward or Backwards?

Dr. Dangas
Download PDF
Part 3: The Known and Unknown of Transcatheter Aortic Valve Thrombosis

Dr. Bax
Download PDF

Session XI: Aiming at the Future of Medicine

10:20 a.m. Part 1: The Future of Promoting Health
Should Children’s Education Be the Priority Focus?

Dr. Fuster
Download PDF
10:45 a.m. Part 2: Evolving Progress of Atherothrombotic Therapies
Reducing Inflammation to Reduce Cardiovascular Risk: The CANTOS Trial

Dr. Ridker
Download PDF
Part 3: The Future of Personalized Cardiovascular Medicine
A Practical Reality or a Dream Not Economical Feasible?

Dr. Califf
Download PDF
11:45 a.m. Course Adjournment